Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTS2R | Q9UKP6 | 12/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.42 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.42 |
| ▸ | KDR | P35968 | 1/20 | 0.42 |
| ▸ | EPHB4 | P54760 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5743996 | 1.00 | UTS2R (0.66) | UTS2RALDH1A1LMNAHTTERBB2 | |
| SCHEMBL5744078 | 0.92 | UTS2R (0.55) | UTS2RALDH1A1LMNAHTTERBB2 | |
| SCHEMBL6821210 | 0.89 | UTS2R (0.65) | UTS2RALDH1A1LMNA | |
| SCHEMBL5741925 | 0.89 | UTS2R (0.65) | UTS2RALDH1A1LMNA | |
| SCHEMBL5834807 | 0.87 | UTS2R (0.70) | UTS2RLMNAERBB2EPHA2KDR | |
| SCHEMBL5834811 | 0.87 | UTS2R (0.70) | UTS2RLMNAERBB2EPHA2KDR | |
| SCHEMBL6679727 | 0.86 | UTS2R (0.58) | UTS2RALDH1A1LMNAERBB2EPHA2 | |
| SCHEMBL6674000 | 0.86 | UTS2R (0.58) | UTS2RERBB2EPHA2KDREPHB4 | |
| SCHEMBL6679730 | 0.86 | UTS2R (0.58) | UTS2RALDH1A1LMNAERBB2EPHA2 | |
| SCHEMBL6674005 | 0.86 | UTS2R (0.58) | UTS2RERBB2EPHA2KDREPHB4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004043463-A2 | SULFONAMIDES | SMITHKLINE BEECHAM CORPORATION (US) | 2004-05-27 | — | — | WO | disclosed |